Moderna Shares Soar on Success of Novel Melanoma Cancer Vaccine

0:00-1:30

Plus: Target’s second-quarter sales suggest the retailer’s turnaround is working. And Cantor Fitzgerald plans to give its hedge-fund clients access to Kalshi’s prediction markets. Alex Ossola hosts. Sign up for WSJ’s free What’s News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor. Hosted by Simple

Publisher

WSJ Minute Briefing

Link

www.wsj.com/podcasts/minute-briefing

Published

August 19, 2026

Duration

2 min

Format

Radio

Category

News · Business News

Source

RSS feed

Host

The Wall Street Journal

WM

WSJ Minute Briefing

@wsjnewshub

#modernasharessoar #success #novelmelanomacancer

The Nile